These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20844609)

  • 1. Dendritic cell-specific antigen delivery by coronavirus vaccine vectors induces long-lasting protective antiviral and antitumor immunity.
    Cervantes-Barragan L; Züst R; Maier R; Sierro S; Janda J; Levy F; Speiser D; Romero P; Rohrlich PS; Ludewig B; Thiel V
    mBio; 2010 Sep; 1(4):. PubMed ID: 20844609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cell-specific delivery of Flt3L by coronavirus vectors secures induction of therapeutic antitumor immunity.
    Perez-Shibayama C; Gil-Cruz C; Nussbacher M; Allgäuer E; Cervantes-Barragan L; Züst R; Ludewig B
    PLoS One; 2013; 8(11):e81442. PubMed ID: 24312302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity.
    Flatz L; Hegazy AN; Bergthaler A; Verschoor A; Claus C; Fernandez M; Gattinoni L; Johnson S; Kreppel F; Kochanek S; Broek Mv; Radbruch A; Lévy F; Lambert PH; Siegrist CA; Restifo NP; Löhning M; Ochsenbein AF; Nabel GJ; Pinschewer DD
    Nat Med; 2010 Mar; 16(3):339-45. PubMed ID: 20139992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
    Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
    Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model.
    Tillman BW; Hayes TL; DeGruijl TD; Douglas JT; Curiel DT
    Cancer Res; 2000 Oct; 60(19):5456-63. PubMed ID: 11034088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class II-associated invariant chain linkage of antigen dramatically improves cell-mediated immunity induced by adenovirus vaccines.
    Holst PJ; Sorensen MR; Mandrup Jensen CM; Orskov C; Thomsen AR; Christensen JP
    J Immunol; 2008 Mar; 180(5):3339-46. PubMed ID: 18292559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentiviral-Vector-Based Dendritic Cell Vaccine Synergizes with Checkpoint Blockade to Clear Chronic Viral Infection.
    Norton TD; Tada T; Leibowitz R; van der Heide V; Homann D; Landau NR
    Mol Ther; 2020 Aug; 28(8):1795-1805. PubMed ID: 32497512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic Cells Cross-Present Immunogenic Lentivector-Encoded Antigen from Transduced Cells to Prime Functional T Cell Immunity.
    Hotblack A; Seshadri S; Zhang L; Hamrang-Yousefi S; Chakraverty R; Escors D; Bennett CL
    Mol Ther; 2017 Feb; 25(2):504-511. PubMed ID: 28153097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Ishida K; Primus FJ; Yamaue H
    Int J Cancer; 2007 Feb; 120(3):585-93. PubMed ID: 17096339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells.
    Bernstein MB; Chakraborty M; Wansley EK; Guo Z; Franzusoff A; Mostböck S; Sabzevari H; Schlom J; Hodge JW
    Vaccine; 2008 Jan; 26(4):509-21. PubMed ID: 18155327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity.
    Nakamura M; Iwahashi M; Nakamori M; Ueda K; Matsuura I; Noguchi K; Yamaue H
    Clin Cancer Res; 2002 Aug; 8(8):2742-9. PubMed ID: 12171908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
    Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
    Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of antigen-specific immune responses induced by canarypox virus vaccines.
    Bos R; van Duikeren S; van Hall T; Lauwen MM; Parrington M; Berinstein NL; McNeil B; Melief CJ; Verbeek JS; van der Burg SH; Offringa R
    J Immunol; 2007 Nov; 179(9):6115-22. PubMed ID: 17947686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transduction of dendritic cells by antigen-encoding lentiviral vectors permits antigen processing and MHC class I-dependent presentation.
    Zarei S; Leuba F; Arrighi JF; Hauser C; Piguet V
    J Allergy Clin Immunol; 2002 Jun; 109(6):988-94. PubMed ID: 12063529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent vaccine therapy with dendritic cells genetically modified by the gene-silencing-resistant retroviral vector GCDNsap.
    Nabekura T; Otsu M; Nagasawa T; Nakauchi H; Onodera M
    Mol Ther; 2006 Feb; 13(2):301-9. PubMed ID: 16311073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity.
    Ludewig B; Barchiesi F; Pericin M; Zinkernagel RM; Hengartner H; Schwendener RA
    Vaccine; 2000 Aug; 19(1):23-32. PubMed ID: 10924783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity.
    Lapteva N; Aldrich M; Weksberg D; Rollins L; Goltsova T; Chen SY; Huang XF
    J Immunother; 2009; 32(2):145-56. PubMed ID: 19238013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral transduction of dendritic cells confers protective antiviral immunity in vivo.
    Zarei S; Abraham S; Arrighi JF; Haller O; Calzascia T; Walker PR; Kündig TM; Hauser C; Piguet V
    J Virol; 2004 Jul; 78(14):7843-5. PubMed ID: 15220461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.